ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Multiple Sclerosis
Sclerosis
Chronic Progressive Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Autoimmune Diseases
Cognitive Dysfunction
Alzheimer Disease

Multiple Sclerosis (MS) trials near Boston, MA, USA:

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) (BEAT-MS)

of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...

Enrolling
Secondary Progressive Multiple Sclerosis
Relapsing Multiple Sclerosis
Procedure: Autologous Hematopoietic Stem Cell Transplantation
Biological: Best Available Therapy (BAT)

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Worcester, Massachusetts, United States and 19 other locations

due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson'...

Enrolling
Adjustment Disorder
Drug: RE104 for Injection

Phase 2

Reunion Neuroscience

Boston, Massachusetts, United States and 16 other locations

This study will evaluate whether ofatumumab is excreted at quantifiable levels and at which concentrations in breast milk of lactating women with RMS...

Enrolling
Multiple Sclerosis
Drug: Ofatunumab

Phase 4

Novartis
Novartis

Brookline, Massachusetts, United States and 21 other locations

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Active, not recruiting
Multiple Sclerosis
Drug: Interferon beta-1a
Drug: Placebo capsule

Phase 3

Novartis
Novartis

Boston, Massachusetts, United States and 72 other locations

of nasal foralumab in patients with non-active secondary progressive multiple sclerosis (SPMS).The primary objectives that this stu...

Enrolling
Secondary Progressive Multiple Sclerosis
Drug: Foralumab
Other: Placebo

Phase 2

Tiziana Life Sciences

Boston, Massachusetts, United States and 6 other locations

(Part 1), a single-ascending subcutaneous (SC) dose (Part 2), and multiple ascending SC doses (Part 3) of RO7121932 in participants with multiple...

Enrolling
Multiple Sclerosis
Drug: RO7121932 IV
Drug: RO7121932 SC

Phase 1

Roche
Roche

Worcester, Massachusetts, United States and 31 other locations

This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis...

Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Placebo
Drug: Obexelimab

Phase 2

Zenas BioPharma

Worcester, Massachusetts, United States and 46 other locations

The primary objective of this trial is to evaluate the safety and reactogenicity of mRNA-1195 in participants with multiple sclerosis...

Enrolling
Multiple Sclerosis
Biological: mRNA-1195
Biological: Placebo

Phase 2

Moderna
Moderna

Boston, Massachusetts, United States and 15 other locations

This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...

Enrolling
Relapsing-Remitting Multiple Sclerosis
Drug: Disease modifying treatment (DMT)
Drug: Ofatumumab

Phase 4

Novartis
Novartis

Worchester, Massachusetts, United States and 42 other locations

This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...

Active, not recruiting
Relapsing-Remitting Multiple Sclerosis
Drug: Ocrelizumab
Drug: Fingolimod

Phase 3

Roche
Roche

Boston, Massachusetts, United States and 105 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems